Vinzenz Särchen

6PUBLICATIONS
20CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells.

Tobias Bexte, Nawid Albinger, Ahmad Al Ajami

|Apr 15, 2024
Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines.

Nahide Yildirim, Lakshmi Sarojam, Victoria M Smith

|Mar 29, 2023
Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids.

Vinzenz Särchen, Lisa Marie Reindl, Sara Wiedemann

|Jan 11, 2022
Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy.

Vinzenz Särchen, Senthan Shanmugalingam, Sarah Kehr

|Jun 02, 2021
Regulation of Death Receptor Signaling by S-Palmitoylation and Detergent-Resistant Membrane Micro Domains-Greasing the Gears of Extrinsic Cell Death Induction, Survival, and Inflammation.

Jürgen Fritsch, Vinzenz Särchen, Wulf Schneider-Brachert

|Apr 03, 2021
Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy.

Philipp Wendel, Lisa Marie Reindl, Tobias Bexte

Pageof 1

Frequent Collaborators

4 joint publications

Meike Vogler

3 joint publications

Lisa Marie Reindl

3 joint publications

Evelyn Ullrich

2 joint publications

Philipp Wendel